Pharmaceuticals and Medical Devices: FDA Oversight

Issue Brief Health Policy Track Serv. 2016 Dec 27:2016:1-74.
No abstract available

MeSH terms

  • Animals
  • Biosimilar Pharmaceuticals
  • Clinical Trials as Topic
  • Commerce / legislation & jurisprudence
  • Consumer Product Safety / legislation & jurisprudence
  • Contrast Media
  • Device Approval / legislation & jurisprudence
  • Dietary Supplements / adverse effects
  • Drug Approval / legislation & jurisprudence*
  • Drug Compounding
  • Drug Industry / legislation & jurisprudence*
  • Drug Labeling
  • Drug Resistance, Microbial
  • Drug-Related Side Effects and Adverse Reactions
  • Drugs, Generic
  • Drugs, Investigational
  • Electronic Nicotine Delivery Systems / adverse effects
  • Fees, Pharmaceutical
  • Fraud
  • Government Regulation*
  • Humans
  • Internet / legislation & jurisprudence
  • Investigational New Drug Application
  • Nonprescription Drugs
  • Opioid-Related Disorders
  • Orphan Drug Production / legislation & jurisprudence
  • Prescription Drug Misuse
  • Prescription Drugs
  • Quality Control
  • Rare Diseases / drug therapy
  • Sexual and Gender Minorities
  • Smoking Prevention
  • Tobacco Products / legislation & jurisprudence
  • Tobacco, Smokeless / adverse effects
  • United States
  • United States Food and Drug Administration*
  • Vaping / adverse effects
  • Veterinary Drugs
  • Zika Virus Infection / drug therapy

Substances

  • Biosimilar Pharmaceuticals
  • Contrast Media
  • Drugs, Generic
  • Drugs, Investigational
  • Nonprescription Drugs
  • Prescription Drugs
  • Veterinary Drugs